Plain-English translation of NCT07509307 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is testing a new medication called to see if it can help people who are overweight or have obesity and also suffer from knee osteoarthritis (wear-and-tear arthritis of the knee). The study will compare this medication to a placebo (a fake injection with no active medicine) to understand how well this treatment works and how safe it is. Participants will receive weekly injections under the skin while also following a reduced-calorie diet and being more physically active.
Knee osteoarthritis causes significant pain and disability, especially in people carrying excess weight. This medication has shown promise in helping people lose weight, and researchers want to understand whether weight loss from this treatment can also reduce knee pain and improve quality of life in people with both conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the new medication or a placebo as a weekly injection under your skin for a set period of time. You will also be asked to follow a reduced-calorie diet and increase your physical activity as part of the treatment plan. You will visit the study site regularly so researchers can check how well the treatment is working, measure your weight and pain levels, and monitor your safety. The study involves 400 participants total, and which treatment you receive will be decided by chance.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States